Τίτλος – Title
|
Μελέτη της Επίδρασης Ανοξίας και Υπογλυκαιμίας στην Έκφραση Νευρωνικών Δεικτών σε Αμφιβληστροειδή και Ιππόκαμπο Επίμυος: Ανάπτυξη ex vivo Μοντέλου Ισχαιμίας Effect of anoxia and hypoglycaemia on the expression of neuronal cell markers in the rat retina and hippocampus: Development of a rat ex vivo ischemia model |
|
Συγγραφέας – Author
|
Άννα Βασιλάκη Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Πανεπιστήμιο Θεσσαλίας, Παπακυριαζή 22, 41222, Λάρισα, Ελλάς Anna Vasilaki Laboratory of Pharmacology, Faculty of Medicine, University of Thessaly, 22 Papakyriazi str., 41222 Larissa, Greece |
|
Παραπομπή – Citation
|
Βασιλάκη,Α. : Μελέτη της Επίδρασης Ανοξίας και Υπογλυκαιμίας στην Έκφραση Νευρωνικών Δεικτών σε Αμφιβληστροειδή και Ιππόκαμπο Επίμυος: Ανάπτυξη ex vivo Μοντέλου Ισχαιμίας, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 25: 25-27 (2007)
Vasilaki,A. : Effect of anoxia and hypoglycaemia on the expression of neuronal cell markers in the rat retina and hippocampus: Development of a rat ex vivo ischemia model, Epitheorese Klin. Farmakol. Farmakokinet. 25: 25-27 (2007)
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
2007 – 2007
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek |
|
Παραγγελία – Αγορά –
Order – Buy |
Ηλεκτρονική Μορφή: pdf (15 €) –
Digital Type: pdf (15 €) pharmakonpress[at]pharmakonpress[.]gr |
|
Λέξεις κλειδιά – Keywords
|
–
Anoxia, hypoglycaemia, neuronal cell markers, rat, ex vivo ischemia model
|
|
Λοιποί Όροι – Other Terms
|
Άρθρο Article |
|
Περίληψη – Summary
|
– Neuronal ischemia leads to neuronal cells death due to glucose and oxygen deprivation. The goal of this study was the development of a rat ex vivo ischemia model for the deferential identification of anoxic and hypoglycaemic actions of ischemia on neuronal tissues which could subsequently used for the screening of possible neuroprotective agents. Methods: The protocol used was a slight modification of one previously reported. In brief, the retina and 500μm thick hippocampal sections were preincubated for 30min in artificial cerebrospinal fluid pH 7.3 (artiCSF) previously buffered with 95%Ο2/5%CO2. Tissues were subsequently incubated in artiCSF previously buffered with 95%Ο2/5%CO2 (control and hypoglycaema) or 95%N2/5%CO2 (anoxia) in the presence (control and anoxic conditions) or absence of glucose (hypoglycaemia: replacement with sucrose). The effect of anoxia and hypoglycaemia on neuronal cell markers’ expression was studied immunohistochemically using antibodies against choline acetyl-transferase (ChAT), γ-amino-butyric acid (GABΑ), neuronal nitric oxide synthase (bNOS) and neurofilament light (NF-L). Results/Conclusions: In the retina, ex vivo hypoglycaemic treatment led to the decrease of ChAT and GABA immunoreactivity in amacrine cells. This decrease was more profound under anoxic conditions. bNOS and NF-L retinal expression as well as GABA hippocampal expression did not seem to be affected by either treatment. As far as ChAT, GABA and bNOS immunoreactivity are concerned our results were in agreement with previous studies of in vivo pressure-induced and in vitro chemical-induced retinal ischemia as well as transient cerebral ischemia. On the other hand, NF-L expression failed to correlate to the decrease of NF-L mRNA levels observed after pressure-induced retinal ischemia/reperfusion. Although further studies are necessary for the assessment of the hypoglycaemia/hypoxia effects on the hippocampal neuronal marker expression this study led to the development of a convenient ex vivo retinal model for the screening of possible neuroprotective agents. |
|
Αναφορές – References
|
1. Benveniste H., et al.: J. Neurochem. 43: 1369-1374 (1984)
2. Beal M.F.: The Neuroscientist 3: 21-27 (1997) 3. Osborne Ν.Ν., et al.: Retinal Eye Res. 23: 91-147 (2004) 4. Izumi Y., et al.: J. Neurosci. Methods 108: 49-55 (2001) 5. Vasilaki A., et al.: Invest. Ophthalmol. Vis. Sci. 42: 1600-1609 (2001) 6. Mastrodimou N., et al.: Naunyn-Schmiedeberg’s Arch. Pharmacol. 37: 44-53 (2005) 7. Dijk F., Kamphius W.: Brain Res. 1026: 205-217 (2004) 8. Dijk F. et al.: Brain Res. 1026: 194-204 (2004) 9. Chidlow G., Osborne N.N.: Brain Res. 963: 298-306 (2003) 10. Bering R., et al.: Exp. Brain Res. 115: 423-429 (1997) |
Online ISSN 1011-6575
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
|
||
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek
|
|
Παραγγελία – Αγορά –
Order – Buy |
pharmakonpress[at]pharmakonpress[.]gr
|
|
pharmakonpress[at]pharmakonpress[.]gr
|